BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36462706)

  • 1. A GC-MS/MS Method for Trace Level Quantification of Six Nitrosamine Impurities (NDMA, NDEA, NEIPA, NDIPA, NDPA, and NDBA) in Commercially Used Organic Solvents: Dichloromethane, Ethyl Acetate, Toluene, and O-xylene.
    Kosuri ER; Bhanti M; Jaywant MA; Han M; Wang X; Obeng M
    J Pharm Sci; 2023 May; 112(5):1225-1230. PubMed ID: 36462706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Quantitation of Four Nitrosamine Impurities in Angiotensin Receptor Blocker Drug Substances.
    Zhang J; Selaya SD; Shakleya D; Mohammad A; Faustino PJ
    J Pharm Sci; 2023 May; 112(5):1246-1254. PubMed ID: 36509171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multi-Analyte LC-MS/MS Method for Determination and Quantification of Six Nitrosamine Impurities in Sartans like Azilsartan, Valsartan, Telmisartan, Olmesartan, Losartan and Irbesartan.
    Gopireddy RR; Maruthapillai A; Mahapatra S
    J Chromatogr Sci; 2024 Feb; 62(2):147-167. PubMed ID: 35830866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and optimization of a HS-SPME-assisted GC-MS/MS method for monitoring nitrosamine impurities in diverse pharmaceuticals.
    Chang SH; Ho HY; Chang CC; Zang CZ; Hsu YH; Lin MC; Tseng SH; Wang DY
    J Pharm Biomed Anal; 2022 Nov; 221():115003. PubMed ID: 36095885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Sensitive Screening Method for Simultaneous Determination of Nine Genotoxic Nitrosamines in Active Pharmaceutical Ingredients by GC-MS.
    Witkowska AB; Giebułtowicz J; Dąbrowska M; Stolarczyk EU
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contamination of valsartan and other sartans, part 1: New findings.
    Sörgel F; Kinzig M; Abdel-Tawab M; Bidmon C; Schreiber A; Ermel S; Wohlfart J; Besa A; Scherf-Clavel O; Holzgrabe U
    J Pharm Biomed Anal; 2019 Aug; 172():395-405. PubMed ID: 31122801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Novel LC-MS/MS Based Analytical Method for the Risk Assessment of Nitrosamines in Pharmaceutical Products and Packaging Materials.
    Kartop RA; Güleli M; Faruzlu FA; Çalışkan C
    J Pharm Sci; 2024 Jun; 113(6):1597-1606. PubMed ID: 38253223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Tripple Quadrupole Mass Spectrometry.
    Solanki R; Wadhwana P; Patel R; Gayakvad B; Kothari C; Patel C
    J Pharm Sci; 2023 May; 112(5):1268-1276. PubMed ID: 36822274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a new methodology for the determination of N-nitrosamines impurities in ranitidine pharmaceuticals using microextraction and gas chromatography-mass spectrometry.
    Giménez-Campillo C; Pastor-Belda M; Campillo N; Hernández-Córdoba M; Viñas P
    Talanta; 2021 Feb; 223(Pt 2):121659. PubMed ID: 33298254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of 10 volatile
    Zhu M; Ye Q; Zhou T; Chen L; Yu L; Li B; Hu J; Zhou M
    Se Pu; 2019 Feb; 37(2):207-215. PubMed ID: 30693730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cautionary Tale: Quantitative LC-HRMS Analytical Procedures for the Analysis of N-Nitrosodimethylamine in Metformin.
    Yang J; Marzan TA; Ye W; Sommers CD; Rodriguez JD; Keire DA
    AAPS J; 2020 Jul; 22(4):89. PubMed ID: 32613429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of dispersive inclusion complex microextraction for the analysis of nitrosamines in medicinal products.
    Tay KSJ; Breadmore MC; Soh ES; See HH
    J Chromatogr A; 2022 Dec; 1685():463605. PubMed ID: 36375217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s.
    Li X; He X; Le Y; Guo X; Bryant MS; Atrakchi AH; McGovern TJ; Davis-Bruno KL; Keire DA; Heflich RH; Mei N
    Arch Toxicol; 2022 Nov; 96(11):3077-3089. PubMed ID: 35882637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Sensitive Headspace Gas Chromatography-Mass Spectrometry Method for the Simultaneous Determination of Nitrosamines in Losartan Active Pharmaceutical Ingredients.
    Wichitnithad W; Sudtanon O; Srisunak P; Cheewatanakornkool K; Nantaphol S; Rojsitthisak P
    ACS Omega; 2021 Apr; 6(16):11048-11058. PubMed ID: 34056258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry with electron ionization for determination of N-nitrosamines in environmental water.
    Chen W; Li X; Huang H; Zhu X; Jiang X; Zhang Y; Cen K; Zhao L; Liu X; Qi S
    Chemosphere; 2017 Feb; 168():1400-1410. PubMed ID: 27923502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of low molecular weight nitrosamines in pharmaceutical products by fast gas chromatography mass spectrometry.
    Kalauz A; Tiringer KV; Horváth V; Kapui I
    J Chromatogr A; 2023 Oct; 1708():464323. PubMed ID: 37696123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Carcinogenic Impurities of N-Nitrosamines in Sartan Pharmaceutical Products Marketed in Brazil: Development and Validation of Method Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Monteiro MA; de Lima PC; Novotny TS; Santana DS; Lima MED; Dantas ASCL; Ferreira LODS; de Souza MN; Maranho RLDN; Ochs SM
    J Pharm Sci; 2023 May; 112(5):1305-1314. PubMed ID: 36657719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine formation in various pharmaceuticals.
    Wichitnithad W; Nantaphol S; Noppakhunsomboon K; Rojsitthisak P
    Saudi Pharm J; 2023 Feb; 31(2):295-311. PubMed ID: 36942272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory Updates and Analytical Methodologies for Nitrosamine Impurities Detection in Sartans, Ranitidine, Nizatidine, and Metformin along with Sample Preparation Techniques.
    Shaik KM; Sarmah B; Wadekar GS; Kumar P
    Crit Rev Anal Chem; 2022; 52(1):53-71. PubMed ID: 32691615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple quantification method for N-nitrosamines in atmospheric particulates based on facile pretreatment and GC-MS/MS.
    Hong Y; Kim KH; Sang BI; Kim H
    Environ Pollut; 2017 Jul; 226():324-334. PubMed ID: 28412030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.